Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T15:41:47.845Z.
Calculation as of: 2026-10-06T15:41:47.845Z.
Quote observation: 2026-10-06T15:40:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4936500bc1589ca9a686c77de910b68cd28581e4c5f82a550ef1f7d6df46dce9
PEG RATIO
N/A
Evogene Ltd.
Market Cap
$3.51M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Evogene Ltd. (EVGN) | $3.51M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.54M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.45M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.42M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.32M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.29M | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.21M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
